#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital nephrogenic diabetes insipidus Microscopic polyangiitis Ichthyosis Scedosporium infection Synovitis Non-Hodgkin's lymphoma refractory Antiphospholipid syndrome Hereditary neuropathic amyloidosis Idiopathic inflammatory myopathy Post transplant lymphoproliferative disorder Lip and/or oral cavity cancer Leukaemia Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Chronic myeloid leukaemia Pleural mesothelioma malignant More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Trials in Disease Langerhans cell sarcoma Marginal zone lymphoma – Trials in Disease Mast cell activation syndrome – Trials in Disease Ewing’s sarcoma – Treatment Hereditary angioedema – Diagnostics Alagille syndrome – Basic Information Mucopolysaccharidosis Pemphigus – Basic Information Pulmonary fibrosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SAR445399 ZUNIBERGENE ROCPARVOVEC Belinostat Lenvatinib Azd5462 Sym023 Hydroxypropylbetadex 64Cu-Dota-Ae105 Certolizumab Pegol Glyceryl Trinitrate STREPTOCOCCUS VIRIDANS N-Acetylhistidine Lisdexamfetamine Dimesylate SUMATRIPTAN Cisatracurium Besilate F510/08 NADOFARAGENE FIRADENOVEC Onasemnogene Abeparvovec Omp66 Levodopa More therapies…

    Learn about Your Condition

    Menopause Muscle injury Narcolepsy Merycism Limb reduction defect Laryngeal cancer stage I Short stature Adenocarcinoma of colon Left ventricular dysfunction Ewing's sarcoma metastatic Hypertriglyceridaemia Systemic mastocytosis Breast cancer stage II Hodgkin's disease refractory Red blood cell abnormality More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Methotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Certolizumab Pegol
    • Leflunomide
    • Sulfasalazine
    Denmark

  • Weekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Short stature
    Investigated Drugs:
    • Somatropin
    Czechia France Greece Poland

  • Supplementary Oxygen Therapy for Patients with Fracture-Related Infection After Limb Debridement and Reconstruction Surgery: A Pilot Randomized Trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Fracture infection
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Long‑Term Monitoring of Malignancy Risk in Early‑Onset Metachromatic Leukodystrophy Patients Treated with atidarsagene autotemcel

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Atidarsagene Autotemcel
    France Germany Italy The Netherlands Sweden

  • Long-Term Safety and Efficacy of Oral Ribitol in Participants with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I/R9)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ribitol
    Denmark Germany Italy The Netherlands Norway

  • Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Thiamine Hydrochloride
    Denmark
Previous Page
1 … 28 29 30 31 32 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!